Caramiphen

DB11504ExperimentalVet approvedSmall molecule

Caramiphen is a cholinergic antagonist used in Parkinson's disease. Additionally, it is used, in combination with phenylpropanolamine, as a cough suppressant and nasal decongestant for the symptomatic treatment of seasonal...

Formula / weight: C₁₈H₂₇NO₂ · 289.419 g/mol (avg)

Resolves to

Compound

UNII97J7NP0XJYCAS77-22-5ChEMBLCHEMBL61946ChEBI135204

Clinical / RWD

RxNorm20191

Structure

InChIKeyOFAIGZWCDGNZGT-UHFFFAOYSA-NSMILESCCN(CC)CCOC(=O)C1(CCCC1)C1=CC=CC=C1

Targets

P11229CHRM1P08172CHRM2

What you can answer from here — as of September 20, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

12+ReferencesStructured and connected to the statements they support

Which drugs share a target with Caramiphen, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account